KMT5B and glioblastoma: Specifically, compared to healthy brain tissue, GBM showed higher levels of 5mC and greatly reduced levels of 5hmC in the CpGi at the promoter and several CpG sites within the KMT5B gene body (Figure 1A and Supplementary Table 3).